Amgen Inc.

NAS : AMGN
Pharmaceuticals
Thousand Oaks CA
Revenue (US$ Millions)$20,063
Revenue Growth (%)7.43%
Net Income (Millions)$5,158
Common Shares Outstanding (Millions)$760
Earnings per Share$6.70
Price To Earnings Ratio25.24
Total Equity (Millions)$25,778
Profit Margin 125.71%
Return on Equity23.34%
Long Term Debt (US$ Millions)$30,215
Debt To Equity Ratio (%)1.17%
Market Capitalization (US$ Millions)$121,124
Total Assets (US$ Millions)$69,009
Return on Assets (%)7.8
Current Assets (US$ Millions)$34,713
Inventories (US$ Millions)$2,647
Current Liabilities (US$ Millions)$7,008
Cost of Goods Sold (US$ Millions)$4,422
Asset Turnover0.29
Inventory Turnover1.56